METASTATIC HORMONE SENSITIVE PROSTATE CANCER
Clinical trials for METASTATIC HORMONE SENSITIVE PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HORMONE SENSITIVE PROSTATE CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HORMONE SENSITIVE PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for prostate cancer patients: stronger treatment when first therapy fails
Disease control Not yet recruitingThis study is for men with advanced prostate cancer that has spread and responds to hormone therapy. It tests if adding chemotherapy (docetaxel) to their current treatment helps when their PSA levels haven't dropped enough after initial therapy. About 320 participants will be ran…
Matched conditions: METASTATIC HORMONE SENSITIVE PROSTATE CANCER
Phase: PHASE3 • Sponsor: Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Massive study tracks advanced prostate cancer treatment in real life
Disease control Not yet recruitingThis study aims to understand how well a drug called darolutamide works in real-world settings for men with advanced prostate cancer that has spread. It will follow about 1,600 men who are already receiving this drug as part of their standard care, either with or without chemothe…
Matched conditions: METASTATIC HORMONE SENSITIVE PROSTATE CANCER
Sponsor: Bayer • Aim: Disease control
Last updated Mar 23, 2026 15:28 UTC